Hans‐christian Siebert - Nanotechnology

Author Information

Hans-Christian Siebert is associated with the RI-B-NT-Research Institute of Bioinformatics and Nanotechnology located at Schauenburgerstr. 116, 24118 Kiel, Germany. His research spans several interdisciplinary fields including biochemistry, biophysics, neuroprotection, and nanotechnology. His work is particularly notable in areas such as amyloid fibrillation inhibition, immune response modulation through dietary interventions, and receptor-ligand binding studies with implications in tissue repair and neurooncology.

Research Contributions

Hans-Christian Siebert has made significant contributions to the scientific community through his diverse and impactful research. In 2022, he co-authored a study demonstrating that a ketogenic diet can inhibit tumor growth by enhancing immune response and reducing immunosuppression. His work also includes the preparation and characterization of neuroprotective phosphatidylserine emulsions, and exploring the inhibition mechanisms of amyloid fibrillation using Sennoside compounds. Siebert's research extends to evaluating the efficacy of chondroprotective food supplements and investigating the biophysical and biochemical properties of collagen hydrolysate. His interdisciplinary approach combines computational and experimental methods to address critical questions in biomedicine.

Aliases

Hans-Christian Siebert is also known by several aliases including H. Siebert, H. C. Siebert, Hans-christian Siebert, H C Siebert, Hans‒christian Siebert, Hans-c Siebert, H-c Siebert, H-c. Siebert, and H.-c. Siebert.

Publication and Citation Metrics

Metric Value
Total Citation Count 3628
H-index 33
Total Number of Papers 99

Publications:

DOI: 10.1007/s10719-020-09913-3

Year: 2020

Partnered Content Networks

Relevant Topics